{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Perez GK"],"funding":["National Cancer Institute","National Institute of Cancer","NCI NIH HHS"],"pagination":["2390-2406"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11236890"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(4)"],"pubmed_abstract":["<h4>Objective</h4>To characterize the representation of Black and Hispanic cancer patients in tobacco treatment trials, and to offer recommendations for future research.<h4>Methods</h4>We conducted two systematic searches of the literature (2018, 2021) using 5 databases (MEDLINE via EBSCO, Pubmed, PsycInfo, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Excerpta Medica Database (EMBASE)) to examine the prevalence of tobacco trials that included Black or Hispanic cancer patients. Two coders independently screened all articles at title, abstract, and full-text to identify eligible trials. Information about the proportion of Black and Hispanic patients included, trial design features, and whether the authors analyzed outcomes for Black and Hispanic patients were documented"],"journal":["Journal of racial and ethnic health disparities"],"pubmed_title":["Do Tobacco Treatment Trials Address Disparities in Smoking Outcomes Among Black and Hispanic Cancer Patients? A Systematic Review of Smoking Cessation Interventions for Black and Hispanic Patients Diagnosed with Cancer."],"pmcid":["PMC11236890"],"funding_grant_id":["K07 CA211955","3R01CA166147 – 02S1","R01 CA166147","3R01CA166147 - 02S1","GKP"],"pubmed_authors":["Perez GK","Rabin JT","Irwin K","Park ER","Tandon M","Ostroff J","Strauss NM","Philpotts L"],"additional_accession":[]},"is_claimable":false,"name":"Do Tobacco Treatment Trials Address Disparities in Smoking Outcomes Among Black and Hispanic Cancer Patients? A Systematic Review of Smoking Cessation Interventions for Black and Hispanic Patients Diagnosed with Cancer.","description":"<h4>Objective</h4>To characterize the representation of Black and Hispanic cancer patients in tobacco treatment trials, and to offer recommendations for future research.<h4>Methods</h4>We conducted two systematic searches of the literature (2018, 2021) using 5 databases (MEDLINE via EBSCO, Pubmed, PsycInfo, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Excerpta Medica Database (EMBASE)) to examine the prevalence of tobacco trials that included Black or Hispanic cancer patients. Two coders independently screened all articles at title, abstract, and full-text to identify eligible trials. Information about the proportion of Black and Hispanic patients included, trial design features, and whether the authors analyzed outcomes for Black and Hispanic patients were documented","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2025-04-05T15:49:34.441Z","creation":"2025-04-05T15:49:34.441Z"},"accession":"S-EPMC11236890","cross_references":{"pubmed":["37468742"],"doi":["10.1007/s40615-023-01705-3"]}}